# Paraguay Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Paraguay HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Paraguay (PRY) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $69.9M - Products: 25 - Buyer markets: 25 - Average CAGR: +39.4% - Global sector size: $380.9B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $253.5B | $6.4M | $92.1B | +44.2% | 18 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $28.6B | $1.7M | $16.2B | +32.0% | 7 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $24.0B | $101.2K | $10.1B | +5.9% | 7 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $5.4B | $12.0K | $6.7B | -10.4% | 2 | +0.0% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $17.0B | $17.6K | $6.5B | +217.3% | 2 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $9.1B | $436.3 | $4.4B | +1.1% | 4 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $8.8B | $114.4K | $3.9B | +81.6% | 2 | +0.0% | | HS 330300 - Perfumes and toilet waters | $5.9B | $13.9K | $3.2B | +11.4% | 2 | +0.0% | | HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.8B | $7.8M | $2.8B | +311.4% | 1 | +0.2% | | HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $3.5K | $2.0B | +32.4% | 1 | +0.0% | | HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $3.6B | $103.3K | $1.8B | +17.4% | 1 | +0.0% | | HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $2.0B | $47.9M | $1.7B | +20.6% | 1 | +2.4% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $1.9B | $2.5K | $1.3B | +59.8% | 2 | +0.0% | | HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $1.5K | $990.0M | +54.6% | 1 | +0.0% | | HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $184.7 | $803.3M | -9.3% | 1 | +0.0% | | HS 281512 - Sodium hydroxide (caustic soda): in aqueous solution (soda lye or liquid soda) | $557.0M | $44.6K | $764.7M | +8.8% | 1 | +0.0% | | HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.3B | $70.0K | $746.8M | -16.0% | 1 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.1B | $44.1K | $718.9M | +10.3% | 1 | +0.0% | | HS 380891 - Insecticides: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $1.6B | $5.4M | $705.1M | +26.6% | 1 | +0.3% | | HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $723.6M | $3.3K | $674.9M | +20.3% | 1 | +0.0% | | HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $936.8M | $11.3 | $580.1M | -10.3% | 1 | +0.0% | | HS 291539 - Acids: saturated acyclic monocarboxylic acids: esters of acetic acid n.e.s. in item no. 2915.3 | $407.2M | $8.0K | $566.9M | +31.5% | 1 | +0.0% | | HS 310520 - Fertilizers, mineral or chemical: containing the three fertilizing elements nitrogen, phosphorus and potassium | $473.9M | $167.8K | $507.9M | +59.8% | 1 | +0.0% | | HS 350691 - Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber | $1.2B | $28.2K | $489.2M | +2.2% | 1 | +0.0% | | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $841.9M | $1.9K | $482.2M | +96.0% | 1 | +0.0% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $36.5B calculated opportunity across 7 products. - Switzerland, Liechtenstein (CHE): $31.0B calculated opportunity across 2 products. - Netherlands (NLD): $14.5B calculated opportunity across 5 products. - Germany (DEU): $12.7B calculated opportunity across 6 products. - China (CHN): $8.7B calculated opportunity across 5 products. - Spain (ESP): $8.3B calculated opportunity across 4 products. - Brazil (BRA): $8.3B calculated opportunity across 8 products. - Belgium (BEL): $7.0B calculated opportunity across 1 products. - Canada (CAN): $5.7B calculated opportunity across 3 products. - France (FRA): $5.5B calculated opportunity across 4 products. - Italy (ITA): $4.9B calculated opportunity across 1 products. - Ireland (IRL): $4.1B calculated opportunity across 2 products. ## Growth stars - HS 382600: +311.4% average CAGR, $2.8B calculated opportunity. - HS 300215: +217.3% average CAGR, $6.5B calculated opportunity. - HS 293399: +96.0% average CAGR, $482.2M calculated opportunity. - HS 382499: +81.6% average CAGR, $3.9B calculated opportunity. - HS 310520: +59.8% average CAGR, $507.9M calculated opportunity. - HS 300290: +59.8% average CAGR, $1.3B calculated opportunity. - HS 294190: +54.6% average CAGR, $990.0M calculated opportunity. - HS 300490: +44.2% average CAGR, $92.1B calculated opportunity. - HS 300420: +32.4% average CAGR, $2.0B calculated opportunity. - HS 300212: +32.0% average CAGR, $16.2B calculated opportunity. ## Diversification opportunities - HS 300490: 18 buyer markets, $92.1B calculated opportunity. - HS 300212: 7 buyer markets, $16.2B calculated opportunity. - HS 330499: 7 buyer markets, $10.1B calculated opportunity. - HS 382200: 4 buyer markets, $4.4B calculated opportunity. - HS 330210: 2 buyer markets, $6.7B calculated opportunity. - HS 300215: 2 buyer markets, $6.5B calculated opportunity. - HS 382499: 2 buyer markets, $3.9B calculated opportunity. - HS 330300: 2 buyer markets, $3.2B calculated opportunity. - HS 300290: 2 buyer markets, $1.3B calculated opportunity. - HS 382600: 1 buyer markets, $2.8B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.